BioSpace News Archive

Nationally renowned cancer researcher and clinician joins a team of top-tier professionals speeding breakthrough treatments closer to home

Sommetrics , a private company developing products and services to improve sleep health, today announced its lead sleep apnea product, aerSleep II, has received FDA Breakthrough Device designation. This program allows for additional FDA feedback to sponsors during the pre-marketing phase but does not alter the basic requirements for market authorization. The Breakthrough Device program is intended to help patients gain mo

Orchard Laboratories, headquartered in West Bloomfield, Mich. (7901 Orchard Lake Road, Suite 100), is the first private laboratory in metro Detroit to operate the new, TaqPath Multiplex Kit to test for SARS-CoV-2, Influenza A and Influenza B.

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. Quarter 3 Results Total revenues for Q3, 2020 were $32.0m, which is broken down as follows: 2019 Quarter 3 2020 Quarter 3 Change US$’000 US$’000 % Point-of-Care 3,880 2,065 (46.8)% Cl

Hand-picked by hundreds of attending angel investors as a stand-out innovator amongst group of highly touted, growth-stage entrepreneurial companies from U.S. and Canada

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare

PRC, a leader in healthcare experience solutions, announced today significant findings from their 2020 National Health Survey focused on senior citizens living in the US.

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced two poster presentations featuring clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) at the upcoming San Antonio Breast Cancer Symposium (SABCS) being held virtually, December 8-11, 2020. Presentation Details: Title: MARIO-3 phase II study initial data evaluating a novel triplet combination of e

Celularity, Inc., a clinical-stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced today the addition of two senior executives to its distinguished leadership team.

Xcelerate Solutions (Xcelerate) is excited to announce a partnership with Certify to deliver thermal scanning capabilities to our clients though the SnapXT Thermal Scanning Terminal.